B7-H3 Enhances Tumor Immunity In Vivo by Costimulating Rapid Clonal Expansion of Antigen-Specific CD8+ Cytolytic T Cells
Liqun Luo(Sun Yat-sen University), Lieping Chen(Yale Cancer Center), Haidong Dong(Mayo Clinic in Arizona), Dallas B. Flies(Mayo Clinic in Arizona), Shengdian Wang(Chinese Academy of Sciences), Fumiya Hirano(Mayo Clinic), Andrew S. Flies(Michigan State University), Yang Liu(Mudanjiang Medical University), Gefeng Zhu(Mayo Clinic in Arizona), Andrei I. Chapoval(Human Genome Sciences (United States)), Julie S. Lau(WinnMed), Koji Tamada(Yamaguchi University)
Cited by 182
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5.1k
Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
|Journal of Clinical Investigation|2015|1.4k
B7-H3: A costimulatory molecule for T cell activation and IFN-γ production
|Nature Immunology|2001|1k
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
|Proceedings of the National Academy of Sciences|2004|767